S039-1733 Screening compound: 2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H,4H,5H,6H,7H,8H,9H-pyrimido[4,5-d]azepin-4-one

S039-1733 Screening compound: 2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H,4H,5H,6H,7H,8H,9H-pyrimido[4,5-d]azepin-4-one
S039-1733 Screening compound: 2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H,4H,5H,6H,7H,8H,9H-pyrimido[4,5-d]azepin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S039-1733
2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H,4H,5H,6H,7H,8H,9H-pyrimido[4,5-d]azepin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S039-1733

Molecular Formula

C19H26N4O2 (C19 H26 N4 O2)

Compound Name

2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H,4H,5H,6H,7H,8H,9H-pyrimido[4,5-d]azepin-4-one

IUPAC name

2-(dimethylamino)-7-[(4-ethoxyphenyl)methyl]-3H4H5H6H7H8H9H-pyrimido[45-d]azepin-4-one

SMILES

CCOc1ccc(CN(CC2)CCC(N=C(N3)N(C)C)=C2C3=O)cc1

InChI

InChI=1S/C19H26N4O2/c1-4-25-15-7-5-14(6-8-15)13-23-11-9-16-17(10-12-23)20-19(22(2)3)21-18(16)24/h5-8H,4,9-13H2,1-3H3,(H,20,21,24)

InChI Key

STODZLPGQZSIQG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD28996016

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

342.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.772

Distribution Coefficient, logD

1.431

Water Solubility, LogSw

-2.49

Polar Surface Area

48.275

Acid Dissociation Constant (pKa)

8.79

Base Dissociation Constant (pKb)

7.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

47.40

S039-1733 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S039-1733 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S039-1733?
Check Price and Availability of S039-1733, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S039-1733 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S039-1733
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S039-1733
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S039-1733 available by request